Globus Medical Inc news

   Watch this stock
Showing stories 1 - 10 of about 74   

Articles published

GMED 27.85 +0.48 (1.75%)
price chart
Zacks Rating on Globus Medical, Inc.
Globus Medical, Inc. (NYSE:GMED) remains a strong buy in the latest set of rankings. The shares have received an average rating of 1 by 11 analysts.
Globus Medical's "Buy" Rating Reiterated at Brean Capital (GMED)  WKRB News
Globus Medical Reports Second Quarter 2015 Results  Business Wire (press release)
Globus Medical, Inc. Engages Grant Thornton LLP as Independent Auditor
AUDUBON, Pa., Jun 09, 2015 (BUSINESS WIRE) -- Globus Medical, Inc. GMED, -0.92% a leading musculoskeletal implant manufacturer, today announced that the Audit Committee of its Board of Directors has engaged Grant Thornton LLP as its independent ...
Globus Medical (GMED) Hits New Lifetime High Today
Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders.
Earnings Surprise in Focus - Globus Medical, Inc. (NYSE:GMED)  Investor Newswire
Analysts Take on Globus Medical, Inc. (NYSE:GMED)  Markets Daily
Globus Medical Announces Acquisition of Transplant Technologies of Texas
AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced that it has acquired allograft tissue processor Transplant Technologies of Texas, Ltd.
Related articles »  
Globus Medical Announces the Acquisition of Branch Medical Group, Inc.
AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced that it has entered into an agreement to acquire Branch Medical Group, Inc. (“BMG”), a third party manufacturer of ...
Two Montco companies agree to $52.9M deal  Philadelphia Business Journal (blog)
Analyst Price Target Update on Globus Medical, Inc.
Globus Medical, Inc. (NYSE:GMED): 8 analysts have set the short term price target of Globus Medical, Inc. (NYSE:GMED) at $29. The standard deviation of short term price target has been estimated at $3.12, implying that the actual price may fluctuate by ...
Inside Sale: Steven Payne Sold 3076 Shares of Globus Medical Inc (NYSE:GMED)
A form filed with the U.S. Security & Exchange Commission on 01/06/2015 informed us that Steven Payne, the Chief Accounting Officer of Globus Medical Inc (NYSE:GMED) 26.87 +0.06 0.22% , miscellaneous manufacturing's company unloaded 3,076 shares ...
Globus Medical Inc (GMED) Disclose Insider Selling : Steven Payne Sells ...  News Watch International
Globus Medical to Participate at Investor Events in June  Business Wire (press release)
Globus Medical Appoints Daniel Scavilla as Senior Vice President and CFO
AUDUBON, Pa., Apr 23, 2015 (BUSINESS WIRE) -- Globus Medical, Inc. GMED, +0.48% a leading musculoskeletal implant manufacturer, today announced it appointed Daniel T. Scavilla as its Senior Vice President and Chief Financial Officer effective May 4, ...
Globus Medical (GMED) Names Scavilla CFO  StreetInsider.com
Harwood Feffer LLP Announces Investigation of Globus Medical, Inc.
NEW YORK, April 27, 2015 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Globus Medical, Inc. ("Globus" or the "Company") (NYSE: GMED), concerning whether the board has breached ...
GMED INVESTOR ALERT: Investigation of Globus Medical, Inc. Announced by Glancy ...
LOS ANGELES--(BUSINESS WIRE)--Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Globus Medical, Inc. (“Globus” or the “Company”) (NYSE: GMED) concerning the Company's and its officers' ...